Menu
Not yet recruiting NCT07115251

Plans4Care: Personalized Dementia Care on Demand

Phase II Interventional Dementia Dementia Alzheimer Type Alzheimer Dementia (AD) Memory Loss

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Plans4Care.
Who it may be relevant to
Registry conditions: Dementia, Dementia Alzheimer Type, Alzheimer Dementia (AD), Memory Loss. Basic parameters: from 21 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The Plans4Care study is a research study funded by the National Institute on Aging (Grant# R44AG084365). The Plans4Care app is designed to help family caregivers address over 90 common care challenges such as behavioral symptoms (anxiety, agitation), functional changes and other concerns, and receive an action plan which provides easy-to-use non-drug strategies, resources, tips and education. The goal of the study is to evaluate whether using the Plans4Care app will help you feel more confident providing care to your family member with dementia, better understand dementia, and enhance your own well-being. You also have the option to talk with a care advisor who can practice use of strategies or address concerns you may have.

Detailed description

We invite caregivers of people with dementia to take part in this research study. You are being asked to evaluate a new online application (web app) called Plans4Care that provides personalized action plans to address common dementia-related care challenges including tips for your own health and wellbeing. This study is being conducted by Plans4Care, Inc. and researchers at Drexel University in collaboration with Thomas Jefferson University.

Participants who are eligible for this study are:

1. A family, friend, or neighbor who self-identifies as having primary care responsibilities for a person with memory loss; 2. \>21 years of age; 3. Able to use an internet capable device (computer, tablet or smart phone), and have stable internet access;

6\. Actively (e.g., past 6 months) managing a dementia-related care challenge.

Interventions

  • Behavioral Plans4Care
    Caregivers assigned to treatment condition will receive: 1) access to the web-app; 2) an orientation to the web-app involving initial set up; and 3) a brief video explaining use of the web-app. Caregivers will be guided through accessing the platform, creating an account and completing a brief set of background questions.

Primary outcome measures

  • Caregiver well-being [Time frame: Baseline, 3 months, 6 months and 12 months]
Secondary outcome measures (3)
  • Caregiver/customer satisfaction (outcome) Net promoter Score [Time frame: 6 months and 12 months]
  • Caregiver satisfaction survey [Time frame: 6 months and 12 months]
  • Health care utilization [Time frame: Baseline, 3 months, 12 months]

Eligibility criteria

Inclusion criteria

  • A family, friend, or neighbor who self-identifies as having primary care responsibilities for a person with memory loss;
  • >21 years of age;
  • Able to use an internet capable device (computer, tablet or smart phone), and have stable internet access;

6\. Actively (e.g., past 6 months) managing a dementia-related care challenge.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Crossover
Masking
Double blind
Primary purpose
Treatment

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT07115251 · 2306009970 · 4R44AG084365

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗